Avieum Life Sciences aims to develop novel inhibitors of Pseudomonas aeruginosa using Fragment based drug discovery approach and by using siderophores as drug delivery agents.
The company also supports global pharmaceutical R&D organizations to accelerate their drug discovery research.
With a proven expertise in synthetic and medicinal chemistry, pre-clinical drug discovery and fragment based drug discovery, the company offer services to support drug discovery from hit identification to lead optimization, custom synthesis, impurity synthesis, reference standards, route scouting and process development.
The company is founded by Dr. Ramesh Kale who did his PhD in Synthetic Organic Chemistry from CSIR-NCL and has 12 years of experience in synthetic and medicinal chemistry, drug discovery and pathogen detection.
Helium Consulting is a software services based company for process manufacturing. The company provides optimization, analytics, control and simulation services to process industries like Refineries, Chemicals and Polymers, Pharma, Power and utilities, Metals and Mining. Helium is founded by Indranath Majumdar who is an alumnus of IIT-Kharagpur and IIM. He is also ex-Aspen Technology, Inc.
Founded in 2010, Shantani Proteome Analytics Pvt. Ltd. is a privately-held biotechnology company that provides novel chemical-proteomics based technologies and services to identify & validate drug targets; thus de-risking molecules and supporting crucial GO / NO-GO decisions throughout the drug discovery process. The company has received SPARSH and SBIRI grant by DBT-BIRAC , GoI. The company has also raised early stage seed capital and angel funding. Shantani is founded by Dr. Chaitanya Saxena who is a seasoned professional and bring successful experience of developing technologies for drug-target deconvolution and drug-target interaction measurements in intact biological systems from his tenure at Eli Lilly & Company. Chaitanya earned a Ph.D. from The Ohio State University, Columbus, OH, USA.
Pratiti is focused on the convergence of technologies such as SMAC, IoT & analytics, and applying this convergence to transform processes and experiences for corporates, consumers and society at large. Initial applications will be in adaptive learning and Industry 4.0. The company proposes to offer IoT (Internet of Things) with focus on industries like bio-tech and manufacturing, product Innovation, user experience and digitization of corporates.